<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37681818</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Factors Associated with Long COVID-19 in a French Multicentric Prospective Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6678</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20176678</ELocationID><Abstract><AbstractText>(1) Background: A substantial proportion of COVID-19 patients continue to experience long-lasting effects that hamper their quality of life. The objectives of this study were (1) to report the prevalence of persistent clinical symptoms 6-12 months after the onset of COVID-19 and (2) to identify potential factors at admission associated with the occurrence of long COVID. (2) Methods: A prospective study was conducted among COVID-19 adult patients, hospitalized in four French university hospitals. Patients were invited to two ambulatory follow-up medical visits, 6-8 months (visit #1) and one year (visit #2) after the onset of their COVID-19. A multivariate logistic regression was performed to assess factors associated with long COVID. (3) Results: In total, 189 patients participated in this study (mean age of 63.4 years). BMI &gt; 30 kg/m<sup>2</sup> (aOR 3.52), AST levels between 31 and 42 U/L (aOR 8.68), and AST levels &gt; 42 U/L (aOR 3.69) were associated with persistent clinical symptoms at visit #1. Anosmia (aOR 13.34), AST levels between 31 and 42 U/L (aOR 10.27), stay in ICU (aOR 5.43), pain (aOR 4.31), and longer time before hospitalization (aOR 1.14) were significantly associated with persistent clinical symptoms at visit #2. Patients with ageusia (aOR 0.17) had a lower risk of long COVID. (4) Conclusions: This study showed that some patients experienced persistent clinical symptoms one year after COVID-19 onset that were associated with some determinants at the acute phase/stage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khanafer</LastName><ForeName>Nagham</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-6455-238X</Identifier><AffiliationInfo><Affiliation>Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon 1 University, CEDEX 07, 69364 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hygiene, Epidemiology, and Prevention, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henaff</LastName><ForeName>Laetitia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon 1 University, CEDEX 07, 69364 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennia</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Hygiene, Epidemiology, and Prevention, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Termoz</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service Recherche et Epid&#xe9;miologie Cliniques, Hospices Civils de Lyon, P&#xf4;le Sant&#xe9; Publique, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapurlat</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Edouard Herriot University Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM UMR 1033, University of Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pr&#xe9;vention des Maladies Osseuses, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escuret</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5298-1002</Identifier><AffiliationInfo><Affiliation>Institut des Agents Infectieux, Hospices Civils de Lyon, 69317 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proriol</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Edouard Herriot University Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duvert</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>INSERM UMR 1033, University of Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pr&#xe9;vention des Maladies Osseuses, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mena</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>INSERM UMR 1033, University of Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pr&#xe9;vention des Maladies Osseuses, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Planckaert</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>INSERM UMR 1033, University of Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pr&#xe9;vention des Maladies Osseuses, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trehet-Mandez</LastName><ForeName>Nad&#xe8;ge</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>INSERM UMR 1033, University of Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pr&#xe9;vention des Maladies Osseuses, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saadatian-Elahi</LastName><ForeName>Mitra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon 1 University, CEDEX 07, 69364 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanhems</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon 1 University, CEDEX 07, 69364 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hygiene, Epidemiology, and Prevention, Edouard Herriot Hospital, Hospices Civils de Lyon, 69003 Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="Y">Ageusia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>8</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37681818</ArticleId><ArticleId IdType="pmc">PMC10488030</ArticleId><ArticleId IdType="doi">10.3390/ijerph20176678</ArticleId><ArticleId IdType="pii">ijerph20176678</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., tenOever B.R. Cardiometabolic syndrome-an emergent feature of Long COVID? Nat. Rev. Immunol. 2022;22:399&#x2013;400. doi: 10.1038/s41577-022-00739-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00739-8</ArticleId><ArticleId IdType="pmc">PMC9127811</ArticleId><ArticleId IdType="pubmed">35610313</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota H.R., Nune A. Long COVID from rheumatology perspective-a narrative review. Clin. Rheumatol. 2021;41:337&#x2013;348. doi: 10.1007/s10067-021-06001-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A., Miwata K., Kitahara Y., Okimoto M., Abe K., Bunthen E., Ouoba S., Akita T., Tanimine N., Ohdan H., et al. Long COVID occurrence in COVID-19 survivors. Sci. Rep. 2022;12:6039. doi: 10.1038/s41598-022-10051-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10051-z</ArticleId><ArticleId IdType="pmc">PMC8996498</ArticleId><ArticleId IdType="pubmed">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.N., Hoang V.T., Dao T.L., Dudouet P., Eldin C., Gautret P. Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: A systematic review. Eur. J. Clin. Microbiol. Infect. Dis. 2022;41:515&#x2013;545. doi: 10.1007/s10096-022-04417-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-022-04417-4</ArticleId><ArticleId IdType="pmc">PMC8830952</ArticleId><ArticleId IdType="pubmed">35142947</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider H.F., Szczepek A.J. Editorial: Neurotological consequences of long COVID. Front. Neurol. 2022;13:1087896. doi: 10.3389/fneur.2022.1087896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1087896</ArticleId><ArticleId IdType="pmc">PMC9720380</ArticleId><ArticleId IdType="pubmed">36479046</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J., Wiernik E., Robineau O., Carrat F., Touvier M., Severi G., de Lamballerie X., Blanch&#xe9; H., Deleuze J.F., Gouraud C., et al. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults during the COVID-19 Pandemic. JAMA Intern. Med. 2021;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadatian-Elahi M., Picot V., Henaff L., Pradel F.K., Escuret V., Dananche C., Elias C., Endtz H.P., Vanhems P. Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV-2 transmission: NOSO-COR Project. BMJ Open. 2020;10:e039088. doi: 10.1136/bmjopen-2020-039088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039088</ArticleId><ArticleId IdType="pmc">PMC7582335</ArticleId><ArticleId IdType="pubmed">33093033</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., on behalf of the WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Felten R., Gallais F., Nazon C., Chatelus E., Pijnenburg L., Mengin A., Gras A., Vidailhet P., Arnould-Michel R., et al. Refining &#x201c;Long-COVID&#x201d; by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection. Infect. Dis. Ther. 2021;10:1747&#x2013;1763. doi: 10.1007/s40121-021-00484-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-021-00484-w</ArticleId><ArticleId IdType="pmc">PMC8270770</ArticleId><ArticleId IdType="pubmed">34245450</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M., Lifelines Corona Research Initiative Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruyere F., Stefic K., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Cruz R.F., Waller M.D., Perrin F., Periselneris J., Norton S., Smith L.J., Patrick T., Walder D., Heitmann A., Lee K., et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7:00655&#x2013;02020. doi: 10.1183/23120541.00655-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00655-2020</ArticleId><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M., Rodriguez N., Diaz-Vieito M., Dominguez M.J., Casal A., Riveiro V., Carinena A., Moreno E., Pose A., Valdes L., et al. Quality of life and persistent symptoms after hospitalization for COVID-19. A prospective observational study comparing ICU with non-ICU patients. Rev. Esp. Anestesiol. Reanim. 2022;69:326&#x2013;335. doi: 10.1016/j.redar.2021.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redar.2021.05.009</ArticleId><ArticleId IdType="pmc">PMC9186450</ArticleId><ArticleId IdType="pubmed">35760688</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., Bontempo G., Marrella F., Tommasini A., Fabris M., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham D.M., Davidson J., Cohen H., Hopkins R.O., Weinert C., Wunsch H., Zawistowski C., Bemis-Dougherty A., Berney S.C., Bienvenu O.J., et al. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders&#x2019; conference. Crit. Care Med. 2012;40:502&#x2013;509. doi: 10.1097/CCM.0b013e318232da75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318232da75</ArticleId><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.H., Kwon H.J., Jang Y.J. Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients. Laryngoscope. 2007;117:1445&#x2013;1449. doi: 10.1097/MLG.0b013e318063e878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLG.0b013e318063e878</ArticleId><ArticleId IdType="pubmed">17572640</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M., Saito K., Min W.P., Vladau C., Toida K., Itoh H., Murakami S. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. 2007;117:272&#x2013;277. doi: 10.1097/01.mlg.0000249922.37381.1e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlg.0000249922.37381.1e</ArticleId><ArticleId IdType="pmc">PMC7165544</ArticleId><ArticleId IdType="pubmed">17277621</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidis I., Haehner A., Frasnelli J., Reden J., Quante G., Damm M., Hummel T. Post-infectious olfactory dysfunction exhibits a seasonal pattern. Rhinology. 2006;44:135&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">16792173</ArticleId></ArticleIdList></Reference><Reference><Citation>Gary J.B., Gallagher L., Joseph P.V., Reed D., Gudis D.A., Overdevest J.B. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician. Am. J. Rhinol. Allergy. 2022;37:95&#x2013;101. doi: 10.1177/19458924221120117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/19458924221120117</ArticleId><ArticleId IdType="pmc">PMC9379596</ArticleId><ArticleId IdType="pubmed">35957578</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.W., Wang X., Xu R.H. Revealing the mystery of persistent smell loss in Long COVID patients. Int. J. Biol. Sci. 2022;18:4795&#x2013;4808. doi: 10.7150/ijbs.73485.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.73485</ArticleId><ArticleId IdType="pmc">PMC9305264</ArticleId><ArticleId IdType="pubmed">35874953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Wang J., Du J., Chen S., Chen S., Li J., Shen B. Changes in Serum Liver Function for Patients with COVID-19: A 1-Year Follow-Up Study. Infect. Drug Resist. 2022;15:1857&#x2013;1870. doi: 10.2147/IDR.S356181.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S356181</ArticleId><ArticleId IdType="pmc">PMC9017694</ArticleId><ArticleId IdType="pubmed">35450115</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C., Notarte K.I., Peligro P.J., Velasco J.V., Ocampo M.J., Henry B.M., Arendt-Nielsen L., Torres-Macho J., Plaza-Manzano G. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022;14:2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A Paradigm for Post-COVID-19 Fatigue Syndrome Analogous to ME/CFS. Front. Neurol. 2021;12:701419. doi: 10.3389/fneur.2021.701419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.701419</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Guziejko K., Talalaj J., Czupryna P., Moniuszko-Malinowska A. Long COVID. Przegl. Epidemiol. 2022;76:287&#x2013;295. doi: 10.32394/pe.76.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.32394/pe.76.27</ArticleId><ArticleId IdType="pubmed">36520039</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi R., Cerda I.H., ElTohamy A., Chen J.A., Stevens C., Liu C.H. Long COVID and psychological distress in young adults: Potential protective effect of a prior mental health diagnosis. J. Affect. Disord. 2023;340:639&#x2013;648. doi: 10.1016/j.jad.2023.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2023.08.031</ArticleId><ArticleId IdType="pubmed">37553019</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicotra A., Masserini F., Calcaterra F., Di Vito C., Doneddu P.E., Pomati S., Nobile-Orazio E., Riva A., Mavilio D., Pantoni L. What do we mean by long-COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection. Eur. J. Neurol. 2023;0:1&#x2013;11. doi: 10.1111/ene.16027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.16027</ArticleId><ArticleId IdType="pubmed">37540896</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimukhamedov C., Mirakhmedova K., Dossybayeva G. Long COVID: The time has come for globally acceptable definitions. Rheumatol. Int. 2023 doi: 10.1007/s00296-023-05414-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-023-05414-2</ArticleId><ArticleId IdType="pubmed">37543536</ArticleId></ArticleIdList></Reference><Reference><Citation>Brightling C.E., Evans R.A. Long COVID: Which symptoms can be attributed to SARS-CoV-2 infection? Lancet. 2022;400:411&#x2013;413. doi: 10.1016/S0140-6736(22)01385-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01385-X</ArticleId><ArticleId IdType="pmc">PMC9352303</ArticleId><ArticleId IdType="pubmed">35933996</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>